Seegene Technologies to Unleash Customized Multiplex PCR Solutions and Support for U.S. Market
Published on: BUSINESS WIRE Mar 07, 2016 Newly established innovation division at Seegene Technologies will deliver customized assays of increased complexity while maintaining sensitivity, specificity,
Seegene and BD Form Worldwide Collaboration to Develop Multiplex Molecular Diagnostic Assays
Published on GenomeWeb MarketWatch RTT News Seegene and BD Form Worldwide Collaboration to Develop Multiplex Molecular Diagnostic Assays Seoul, Korea, and Baltimore, MD, September 14, 2015 —
Seegene and QIAGEN Enter into a Collaboration to Develop Multiplex Molecular Diagnostic Assay
Published on: GenomeWeb Nasdaq streetinsider Seoul, Korea, and Hilden, Germany, July 8, 2015 — Seegene Inc. (096530.KQ), today announced that it has entered into aworldwide collaboration agreement with QIAGEN
Seegene Establishes U.S. Subsidiary. Seegene Technologies Inc. to Drive Growth in the U.S. and Global Molecular Diagnostics Market
Published on: GenomeWeb Seegene Establishes U.S. Subsidiary Seegene Technologies Inc. to Drive Growth in the U.S. and Global Molecular Diagnostics Market CONCORD, CA and SEOUL,
Press Release Example #1903
Walnut Creek, California – April 14, 2020 – Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore
Press Release Example #1902
Published date is April 16, 2021 @ 1:03pm, but I changed it manually to the “actual” date of the release which is in 2019.